Effects of a Self-Regulation Based E-MOTE Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients

介入なし：コントロールグループ

日常のお手入れ

実験的：Intervention Group

The intervention group will receive the E-MOTE program, which includes emotional assessments, a self-relaxation training session, and a Q&A session delivered via the Kebbi AI robot during hospitalization. After discharge, participants will continue to receive the program through the LINE Official Account.

他の：E-MOTE group

Participants in the experimental group will receive the E-MOTE program during hospitalization on the day before surgery, postoperative day 1, and postoperative day 2 via the AI robot. The intervention includes an emotional assessment, followed by dialogue modules tailored to the participant's level of emotional distress, emotion-generated empathetic conversations, a self-affirmation relaxation training session, and a Q&A session. After discharge, participants will continue to receive the E-MOTE program through the LINE Official Account.

苦痛

研究者は主要なアウトカム指標としてDistress Thermometer（DT）を使用しました。 この尺度は11段階のリッカート尺度を使用しており、0は全く苦痛がないことを示し、10は最も深刻な苦痛を表します。スコアが高いほど、より深刻な苦痛を示します。 スコアが4以上の場合、Problem List（PL）を使用して、精神的苦痛に寄与する要因をさらに特定します。

Depression

Investigators utilized the Patient Health Questionnaire (PHQ-9) as the primary outcome measure to assess depression. The scale consists of 9 items, each rated on a 4-point Likert scale (0 = not at all, 3 = nearly every day). The total score ranges from 0 to 27, and depression severity can be categorized as mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20 or above).Higher score indicates a more severe depression.

Quality of Life Measurement

Investigator use the partial itmes of European Organisation for Research and Treatment of Cancer (EORTC QLQ-C30) to measure quality of life. These two item is scored on a scale from 1 to 7, with higher scores indicating better quality of life.

Symptom Severity

Investigators utilized the Numerical Rating Scale to assess participants' subjective experiences by measuring the severity of various symptoms over the past week. Each symptom was rated on a scale from 0 to 10 (0 = no symptoms at all, 10 = the worst severity the participant can imagine). Higher score indicate more severity. This items included difficulty urinating, lower limb lymphedema, hot flashes caused by premature menopause, and perineal dryness.

Stress Index

Objective physiological indicators were measured using wearable smart wristbands, and heart rate variability (HRV) was converted into a stress index using a predefined formula.